Global Catheter Stabilization Devices Market Overview
Catheter Stabilization Devices Market Size was valued at USD 0.9 Billion in 2023. The Catheter Stabilization Devices market Product Type is projected to grow from USD 0.98 Billion in 2024 to USD 1.9 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.51% during the forecast period (2024 - 2032).A high prevalence of lifestyle disorders and rising demand for minimally invasive treatments, are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The market is expected to grow as a result of rising demand for minimally invasive procedures, the prevalence of lifestyle diseases such as cancer, cardiovascular disease, and renal failure, and the number of procedures that would necessitate these devices for postoperative care. The need for these gadgets rises more as the population ages.
Intravascular catheters are widely used in today's medical facilities across the world. As their popularity has grown, they have quickly become an indispensable part of modern medical facilities. The use of these tools in the treatment of urinary disorders is growing in popularity. As a result, their expanding deployment across a wide range of industries should eventually drive up demand for stabilizing tools.
The pandemic crisis had a profound effect on the medical field. Patients with COVID-19 often need intubation as part of their treatment. Ventilators, intubation tools, and ventilation stabilization instruments such catheter stabilization devices saw increased use as the number of Corona patients increased. Patients with COVID 19 were given IVIG (Intravenous Immunoglobulin) as a kind of supportive treatment to reduce the hazards associated with catheter movement, which increases the necessity for catheter stabilizing devices.
Widespread usage contributes to a rise in the incidence of bloodstream infections. Since its stability is so crucial in preventing secondary issues, it has become a cornerstone of patient treatment. The costs, duration of hospital stay, and severity of patient morbidity associated with treating these infections are all on the rise.
For example, Abbott announced on 2nd February 2023 two clearances for its expanding line of electrophysiological devices in the global market. In the TactiFlex Ablation Catheter Sensor Enabled, a flexible tip and contact force sensing have been implemented, making it the first and only ablation catheter of its kind to receive CE Mark1 for the treatment of irregular cardiac rhythms such as AFib. The US FDA recently approved FlexAbility Ablation Catheter, Sensor Enabled, produced by Abbott, to be used in the management of a wider range of heart claims diseases.
In September 2022 (Acquisition): Starboard Medical acquired Braun Medical with an innovative product launch Clik-FIX catheter fixation device. The B. Braun acquisition will enable peripheral intravenous (IV) therapy solutions that enhance patient experience and outcomes through product and programmatic innovations.
April 2022: Bedal signed a distribution agreement with Gulf Medical Co. Ltd. (GMC) for Saudi Arabia and Bahrain. GMC would distribute Bedal’s offerings into these two markets, which are major markets for the use of catheter stabilization devices within Gulf countries.
March 2022: Tractus Vascular announced the successful initial human use of its Tractus Crossing Support Catheter.
CATHETRIX is an advanced medical device company producing smart urinary (Foley) catheters at MEDICA 2021. Dusseldorf, Germany, unveiled its novel catheter stabilizer designed to prevent UTIs and inadvertent Foley catheter extractions in November 2021.
For instance, STARBOARD MEDICAL, INC., a medical technology firm focused on enhancing patient catheter securement, disclosed on June 2021 that it had received another USPTO issued US Patent No.11,020,566 B2 covering Starboard’s Clik-FIX line of securements. The patent strengthens the company's intellectual property portfolio as well as advancing its patent claims adds new design improvements.
In addition, Argon Medical Devices announced the introduction of a Skater mini-loop drainage catheter in March 2021, which is placed across the skin using image guidance and can be a minimally invasive method of taking away or draining unwanted fluid accumulation.
Catheter Stabilization Devices Market Trends
- Increasing demand for minimally invasive surgeries is driving the market growth
Increased demand for minimally invasive procedures, the increasing frequency of lifestyle illnesses including cancer, cardiovascular disease, and renal failure, as well as an increase in the number of procedures that would require these devices for postoperative care, are all expected to propel the market. Additionally, the population's ageing increases the demand for these devices. The World Health Organisation (WHO) has designated the COVID-19 as an emergent health issue. The healthcare industry had been significantly impacted by the pandemic issue. Intubation was one of the most important procedures used to treat COVID-19 patients. Due to the rise of Corona patients, there was a greater need for ventilators, intubation equipment, and ventilation stabilisation instruments such catheter stabilisation devices. IVIG (Intravenous Immunoglobin) was used as supportive therapy for COVID 19 patients in order to lessen the risks associated with catheter movement, which adds to the increased demand for catheter stabilising devices.
All across the world, intravascular catheter use is a crucial component of contemporary healthcare. With an increase in utilisation, these have developed into a necessary component in hospitals and clinics. Hospitals and clinics buy more than 150 million of these devices annually for the delivery of drugs, IV fluids, parenteral nutrition, and hemodynamic status monitoring, according to a 3M article. Additionally, it predicts the annual placement of more than 5 million central intravascular catheters. It is becoming more common to have urinary diseases such cystitis, urine retention, urinary incontinence, benign prostate hyperplasia, kidney stones, and other conditions that cause bladder dysfunction. According to the National Association for Continence, over 25 million Americans experience incontinence of some kind. These gadgets are becoming more and more in demand for the treatment of individuals with urinary disorders. Thus, it is projected that the expanding use of these on a scale in a variety of application areas would ultimately contribute to the increased use of stabilisation devices.
According to the Joint Commission's monograph "A Challenge, A Perspective", 80,000 CLABSIs are thought to happen in ICUs annually in the United States. If patients outside the IUs are included, the number of CLABSI cases rises to 250,000 annually. One of the main causes of the necessity for their good and efficient securement is an increase in the incidence of such illnesses. To lower the risk of intravascular catheter-related infections, the CDC advises using securement devices. The best practise for the management of indwelling catheters, according to the Australia and New Zealand Urological Nurses Society's (ANZUNS) catheterization clinical guidelines, is the use of a securement device.Thus, driving the Catheter Stabilization Devices market revenue.
Catheter Stabilization Devices Market Segment Insights
Catheter Stabilization Devices Product Type Insights
The Catheter Stabilization Devices market segmentation, based on product type, includes arterial securement devices, central venous catheter securement devices, peripheral securement devices, chest drainage tube securement devices, abdominal drainage tubes securement devices, epidural securement devices, and other devices. Arterial securement devices segment dominated the market in 2022. Throughout the world, arterial catheters are routinely utilised in standard contemporary medical procedures. This industry kept the lion's share of the market due to the widespread use of arterial catheters in several operations for treating cancer and cardiovascular problems. Because of how frequently these devices are used, security is essential to reducing usage-related issues.
Catheter Stabilization Devices Application Insights
The Catheter Stabilization Devices market segmentation, based on application, includes cardiovascular procedures, radiology, general surgery, urological procedures, respiratory procedures, gastric and oropharyngeal procedures, and others. Urological procedures segment dominated the market in 2022. The adoption of strategic initiatives by market participants is one of the primary drivers of the segment's growth. Another factor driving segment expansion is the rise in chronic renal disorders that necessitate kidney transplants and surgical operations. For instance, according to a study released by the Health Resources & Services Administration (HRSA) in March 2022, in the United States in 2021, there were about 24,670 kidney transplants.
Catheter Stabilization Devices End User Insights
The Catheter Stabilization Devices market segmentation, based on end user, includes hospitals & clinics, home healthcare providers, diagnostic centers and others. Hospitals & clinics segment dominated the Catheter Stabilization Devices market in 2022. In hospitals, a lot of surgeries are carried out. In hospitals, catheters are frequently utilised for a variety of therapies. In hospitalised patients, the prevalence of illnesses linked to their use is significant. The most often reported hospital acquired infections (HAIs) are catheter-associated urinary tract infections (CAUTI), and their incidence is on the rise.
Figure 1: Catheter Stabilization Devices Market, by End User, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
July 2023: A business combination deal between BlueRiver and Spinal Stabilization Technologies was signed in July of 2023, and the two companies subsequently listed on a major stock exchange. Spinal Stabilization Technologies, a medical device manufacturer located in the United States, has agreed to merge with BlueRiver Acquisition Corp., a publicly listed special purpose acquisition firm. Lumbar implants for nucleus pulposus replacements are among the many issues that Spinal Stabilization Technologies has taken on in an effort to alleviate lower back discomfort. The company's flagship product, PerQdisc, is a motion-preserving surgical treatment that replicates the nucleus pulposus's function. However, it has not yet obtained FDA clearance.
Catheter Stabilization Devices Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Catheter Stabilization Devices Market dominated this market in 2022 (45.80%). The significant market share in this area can be ascribed to the increased volume of operations, which raises the demand for stabilisation devices. One of the causes causing the market to rise is the widespread use of catheterization procedures in examination, diagnosis, and treatment. Furthermore, it is projected that rising intravascular catheter utilisation in this region will fuel the market.Further, the U.S. Catheter Stabilization Devices market held the largest market share, and the Canada Catheter Stabilization Devices market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: CATHETER STABILIZATION DEVICES MARKET SHARE BY REGION 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Catheter Stabilization Devices market accounted for the healthy market share in 2022. The increase in surgical operations, the presence of powerful market competitors, and enhanced healthcare infrastructure are the main drivers of market growth.Further, the German Catheter Stabilization Devices market held the largest market share, and the U.K Catheter Stabilization Devices market was the fastest growing market in the European region.
The Asia Pacific Catheter Stabilization Devices market is expected to register significant growth from 2023 to 2032. This is brought on by a sizable patient pool, expanding target population, high unmet demands, and developing regional infrastructure. Growth in this region is anticipated to be boosted by rising demand for various surgeries, bettering healthcare facilities, and raising public and professional knowledge. Moreover, China’s Catheter Stabilization Devices market held the largest market share, and the Indian Catheter Stabilization Devices market was the fastest growing market in the Asia-Pacific region.
Catheter Stabilization Devices Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Catheter Stabilization Devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Catheter Stabilization Devices Industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Catheter Stabilization Devices Industry to benefit clients and increase the market sector. In recent years, the Catheter Stabilization Devices Industry has offered some of the most significant advantages to medicine. Major players in the Catheter Stabilization Devices market, including 3M Company, Braun Melsungen Ag, Baxter International, Inc., R. Bard, Inc., Centurion Medical Products, Convatec, Inc, C. Johnson Company, Inc, Medtronic PLC, Merit Medical Systems, Inc, Smiths Group PLC, and TIDI Products, LLC, are attempting to increase market demand by investing in research and development operations.
Manufacturer of specialised medical devices for surgical use Argon Medical Devices. Through a network of direct sales representatives and top distributors, the company distributes medical devices used in intervention procedures, providing physician customers with cutting-edge technologies to enhance clinical efficacy and outcomes. The Skater mini-loop drainage catheter, which is inserted through the skin under image guidance as a minimally invasive treatment to remove or drain an undesirable fluid collection, was announced by Argon Medical Devices in March 2021.
A medical equipment business called Bedal creates a patented method of fastening catheters. It helps to increase patient comfort while delivering powerful catheter fixation. The business is headquartered in Diepenbeek, Belgium, and was established in 2011. Bedal and Gulf Medical Co. Ltd. (GMC) agreed to distribute medical supplies to Saudi Arabia and Bahrain in April 2022. GMC will distribute Bedal goods in the Saudi Arabian and Bahraini markets, making up a sizable portion of the Gulf region's market for catheter stabilisation devices.
Key Companies in the Catheter Stabilization Devices market include
-
3M Company
-
Braun Melsungen Ag
-
Baxter International, Inc.
-
R. Bard, Inc.
-
Centurion Medical Products
-
Convatec, Inc
-
C. Johnson Company, Inc
-
Medtronic PLC
-
Merit Medical Systems, Inc
-
Smiths Group PLC
-
TIDI Products, LLC
Catheter Stabilization Devices Industry Developments
November 2021:At MEDICA 2021, which was held from November 15–18 in Düsseldorf, Germany, CATHETRIX, a pioneer in the development of urinary (Foley) smart catheter fixations, showcased its brand-new catheter stabiliser for the avoidance of UTIs and unintentional Foley catheter extractions.
March 2022:The Tractus Crossing Support Catheter was initially used by a person, according to Tractus Vascular.
Catheter Stabilization Devices Market Segmentation
Catheter Stabilization Devices Product Type Outlook
-
Arterial Securement Devices
-
Central Venous Catheter Securement Devices
-
Peripheral Securement Devices
-
Chest Drainage Tube Securement Devices
-
Abdominal Drainage Tubes Securement Devices
-
Epidural Securement Devices
-
Other Devices
Catheter Stabilization Devices Application Outlook
Catheter Stabilization Devices End User Outlook
Catheter Stabilization Devices Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
| Report Attribute/Metric |
Details |
| Market Size 2023 |
USD 0.9 Billion |
| Market Size 2024 |
USD 0.98 Billion |
| Market Size 2032 |
USD 1.9 Billion |
| Compound Annual Growth Rate (CAGR) |
8.51% (2024-2032) |
| Base Year |
2023 |
| Market Forecast Period |
2024-2032 |
| Historical Data |
2018- 2022 |
| Market Forecast Units |
Value (USD Billion) |
| Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
Product Type, Application, End User, and Region |
| Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled |
3M Company, Braun Melsungen Ag, Baxter International, Inc., R. Bard, Inc., Centurion Medical Products, Convatec, Inc, C. Johnson Company, Inc, Medtronic PLC, Merit Medical Systems, Inc, Smiths Group PLC, and TIDI Products, LLC |
| Key Market Opportunities |
New product launches |
| Key Market Dynamics |
Increasing demand for minimally invasive surgeries and high prevalence of lifestyle diseases |
Frequently Asked Questions (FAQ) :
The Catheter Stabilization Devices market size was valued at USD 0.9 Billion in 2023.
The market is projected to grow at a CAGR of 8.51% during the forecast period, 2024-2032.
North America had the largest share in the market
The key players in the market are 3M Company, Braun Melsungen Ag, Baxter International, Inc., R. Bard, Inc., Centurion Medical Products, Convatec, Inc, C. Johnson Company, Inc, Medtronic PLC, Merit Medical Systems, Inc, Smiths Group PLC, and TIDI Products, LLC
The Arterial Securement Devices Product Type dominated the market in 2022.
The Urological Procedures Application had the largest share in the market.
